Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bioanalysis

Showing results (751-760 of 3,553) with videos related to

Pageof 356
Sort By:
Bioanalysis|July 17, 2012
Modification without impact: a case study in clinical assay failure due to lipemiaGraeme T Clark, Paul J Russell, Steven Westwood
Bioanalysis|July 17, 2012
RP-HPLC-UV method coupled with post-column iodine-azide reaction for determination of free captopril in urine samplesAdam Łuczak, Robert Zakrzewski, Miłosz Dobrogowski
Bioanalysis|July 17, 2012
Strategic selection and development of immunogenicity binding methodsAna T Menendez
Bioanalysis|July 27, 2012
Anti-doping analysis and the OlympicsPatrick Schamasch, Olivier Rabin
Bioanalysis|July 27, 2012
Current limitations in analytical strategiesDavid Howman
Bioanalysis|July 27, 2012
Ethical considerations in anti-doping analysisThomas H Murray
Bioanalysis|July 27, 2012
Interview: partnering with the industry: the Olympic laboratory modelDavid A Cowan, Campbell P Barker
Bioanalysis|July 27, 2012
Potential and limitations of alternative specimens in doping controlDetlef Thieme
Bioanalysis|July 27, 2012
Challenges and perspectives in anti-doping testingPatrick Schamasch, Olivier Rabin
Bioanalysis|January 31, 2015
Targeted LC-MS quantification of intact TAT-fusion therapeutics: a case studyXiaoping Zhao, Jianan Sun, Lu Sun, et al.
Pageof 356

Showing results (751-760 of 3,553) with videos related to

Sort By:
Pageof 356
Bioanalysis|July 17, 2012
Modification without impact: a case study in clinical assay failure due to lipemiaGraeme T Clark, Paul J Russell, Steven Westwood
Bioanalysis|July 17, 2012
RP-HPLC-UV method coupled with post-column iodine-azide reaction for determination of free captopril in urine samplesAdam Łuczak, Robert Zakrzewski, Miłosz Dobrogowski
Bioanalysis|July 17, 2012
Strategic selection and development of immunogenicity binding methodsAna T Menendez
Bioanalysis|July 27, 2012
Anti-doping analysis and the OlympicsPatrick Schamasch, Olivier Rabin
Bioanalysis|July 27, 2012
Current limitations in analytical strategiesDavid Howman
Bioanalysis|July 27, 2012
Ethical considerations in anti-doping analysisThomas H Murray
Bioanalysis|July 27, 2012
Interview: partnering with the industry: the Olympic laboratory modelDavid A Cowan, Campbell P Barker
Bioanalysis|July 27, 2012
Potential and limitations of alternative specimens in doping controlDetlef Thieme
Bioanalysis|July 27, 2012
Challenges and perspectives in anti-doping testingPatrick Schamasch, Olivier Rabin
Bioanalysis|January 31, 2015
Targeted LC-MS quantification of intact TAT-fusion therapeutics: a case studyXiaoping Zhao, Jianan Sun, Lu Sun, et al.
Pageof 356